stroke ischemic

17/4/2015 IschemicStroke

http://emedicine.medscape.com/article/1916852overview#a0156 1/18

IschemicStrokeAuthor:EdwardCJauch,MD,MS,FAHA,FACEPChiefEditor:HelmiLLutsep,MDmore...

Updated:Jan20,2015

PracticeEssentialsIschemicstroke(seetheimagebelow)ischaracterizedbythesuddenlossofbloodcirculationtoanareaofthebrain,resultinginacorrespondinglossofneurologicfunction.Acuteischemicstrokeiscausedbythromboticorembolicocclusionofacerebralarteryandismorecommonthanhemorrhagicstroke.

Maximumintensityprojection(MIP)imagefromacomputedtomographyangiogram(CTA)demonstratesafillingdefectorhighgradestenosisatthebranchingpointoftherightmiddlecerebralartery(MCA)trunk(redcircle),suspiciousforthrombusorembolus.CTAishighlyaccurateindetectinglargevesselstenosisandocclusions,whichaccountforapproximatelyonethirdofischemicstrokes.

SeeAcuteStroke,aCriticalImagesslideshow,formoreinformationonincidence,presentation,intervention,andadditionalresources.

Essentialupdate:Studyindicatesintraarterialtreatmentimprovesfunctionalrecoveryinacuteischemicstroke

ArandomizedclinicaltrialfromtheNetherlandsindicatesthatendovascularinterventionbenefitsfunctionaloutcomesinpatientswithacuteischemicstrokeresultingfromaproximalintracranialarterialocclusion.Inthestudy,byBerkhemeretal,500patientswererandomizedtoreceiveintraarterialtreatment(within6hoursofsymptomonset)orusualtreatmentalone.Although89%ofthepatientsweretreatedwithtissuetypeplasminogenactivator(tPA)priortorandomization,onlythosewhowerefoundoncomputedtomography(CT)angiographytostillhaveaproximalarterialocclusionwereenteredintothestudy.Inmostofthepatientswhoreceivedintraarterialtreatment,theprocedurewasperformedwithlatestgenerationstentretrievers.[1,2]

Theinvestigatorsfoundthatat90days,therateoffunctionalindependence(modifiedRankinscalescoreof02)intheintraarterialtreatmentgroupwas32.6%,comparedwith19.1%intheusualtreatmentonlygroup,whileafter57days,theNationalInstitutesofHealthStrokeScale(NIHSS)scorewasanaverageof2.9pointslowerintheintraarterialtreatmentpatientsthanitwasintheothergroup.Thetwogroupsdidnotdiffersignificantlywithregardtotherateofmoralityorsymptomaticintracerebralhemorrhage.

Signsandsymptoms

Considerstrokeinanypatientpresentingwithacuteneurologicdeficitoranyalterationinlevelofconsciousness.Commonstrokesignsandsymptomsincludethefollowing:

Abruptonsetofhemiparesis,monoparesis,or(rarely)quadriparesisHemisensorydeficitsMonocularorbinocularvisuallossVisualfielddeficitsDiplopiaDysarthriaFacialdroopAtaxiaVertigo(rarelyinisolation)NystagmusAphasiaSuddendecreaseinlevelofconsciousness

Althoughsuchsymptomscanoccuralone,theyaremorelikelytooccurincombination.Nohistoricalfeaturedistinguishesischemicfromhemorrhagicstroke,althoughnausea,vomiting,headache,andsuddenchangeinlevelofconsciousnessaremorecommoninhemorrhagicstrokes.Inyoungerpatients,ahistoryofrecenttrauma,coagulopathies,illicitdruguse(especiallycocaine),migraines,oruseoforalcontraceptivesshouldbeelicited.

Withtheavailabilityoffibrinolytictherapyforacuteischemicstrokeinselectedpatients,thephysicianmustbeabletoperformabriefbutaccurateneurologicexaminationonpatientswithsuspectedstrokesyndromes.Thegoalsoftheneurologicexaminationincludethefollowing:

ConfirmingthepresenceofastrokesyndromeDistinguishingstrokefromstrokemimicsEstablishinganeurologicbaseline,shouldthepatient'sconditionimproveordeteriorate



Establishingstrokeseverity,usingastructuredneurologicexamandscore(NationalInstitutesofHealthStrokeScale[NIHSS])toassistinprognosisandtherapeuticselection

Essentialcomponentsoftheneurologicexaminationincludethefollowingevaluations:

CranialnervesMotorfunctionSensoryfunctionCerebellarfunctionGaitDeeptendonreflexesLanguage(expressiveandreceptivecapabilities)Mentalstatusandlevelofconsciousness

Theskullandspinealsoshouldbeexamined,andsignsofmeningismusshouldbesought.

SeeClinicalPresentationformoredetail.

Diagnosis

Emergentbrainimagingisessentialforconfirmingthediagnosisofischemicstroke.Noncontrastcomputedtomography(CT)scanningisthemostcommonlyusedformofneuroimagingintheacuteevaluationofpatientswithapparentacutestroke.Thefollowingneuroimagingtechniquesarealsoused:

CTangiographyandCTperfusionscanningMagneticresonanceimaging(MRI)CarotidduplexscanningDigitalsubtractionangiography

Lumbarpuncture

AlumbarpunctureisrequiredtoruleoutmeningitisorsubarachnoidhemorrhagewhentheCTscanisnegativebuttheclinicalsuspicionremainshigh

Laboratorystudies

Laboratorytestsperformedinthediagnosisandevaluationofischemicstrokeincludethefollowing:

Completebloodcount(CBC):Abaselinestudythatmayrevealacauseforthestroke(eg,polycythemia,thrombocytosis,thrombocytopenia,leukemia)orprovideevidenceofconcurrentillness(eg,anemia)Basicchemistrypanel:Abaselinestudythatmayrevealastrokemimic(eg,hypoglycemia,hyponatremia)orprovideevidenceofconcurrentillness(eg,diabetes,renalinsufficiency)Coagulationstudies:MayrevealacoagulopathyandareusefulwhenfibrinolyticsoranticoagulantsaretobeusedCardiacbiomarkers:ImportantbecauseoftheassociationofcerebralvasculardiseaseandcoronaryarterydiseaseToxicologyscreening:Mayassistinidentifyingintoxicatedpatientswithsymptoms/behaviormimickingstrokesyndromesPregnancytesting:Aurinepregnancytestshouldbeobtainedforallwomenofchildbearingagewithstrokesymptomsrecombinanttissuetypeplasminogenactivator(rtPA)isapregnancyclassCagentArterialbloodgasanalysis:Inselectedpatientswithsuspectedhypoxemia,arterialbloodgasdefinestheseverityofhypoxemiaandmaybeusedtodetectacidbasedisturbances

SeeWorkupformoredetail.

Management

Thegoalfortheemergentmanagementofstrokeistocompletethefollowingwithin60minutesofpatientarrival[3]:

Assessairway,breathing,andcirculation(ABCs)andstabilizethepatientasnecessaryCompletetheinitialevaluationandassessment,includingimagingandlaboratorystudiesInitiatereperfusiontherapy,ifappropriate

Criticaltreatmentdecisionsfocusonthefollowing:

TheneedforairwaymanagementOptimalbloodpressurecontrolIdentifyingpotentialreperfusiontherapies(eg,intravenousfibrinolysiswithrtPAorintraarterialapproaches)

Involvementofaphysicianwithaspecialinterestinstrokeisideal.Strokecareunitswithspeciallytrainedpersonnelexistandimproveoutcomes.

Ischemicstroketherapiesincludethefollowing:

FibrinolytictherapyAntiplateletagents[4,5]Mechanicalthrombectomy

Treatmentofcomorbidconditionsmayincludethefollowing:

ReducefeverCorrecthypotension/significanthypertensionCorrecthypoxiaCorrecthypoglycemiaManagecardiacarrhythmiasManagemyocardialischemia

Strokeprevention



Primarystrokepreventionreferstothetreatmentofindividualswithnoprevioushistoryofstroke.Measuresmayincludeuseofthefollowing:

PlateletantiaggregantsStatinsExerciseLifestyleinterventions(eg,smokingcessation,alcoholmoderation)

Secondarypreventionreferstothetreatmentofindividualswhohavealreadyhadastroke.Measuresmayincludeuseofthefollowing:

PlateletantiaggregantsAntihypertensivesStatinsLifestyleinterventions

SeeTreatmentandMedicationformoredetail.

BackgroundAcuteischemicstroke(AIS)ischaracterizedbythesuddenlossofbloodcirculationtoanareaofthebrain,typicallyinavascularterritory,resultinginacorrespondinglossofneurologicfunction.Alsopreviouslycalledcerebrovascularaccident(CVA)orstrokesyndrome,strokeisanonspecificstateofbraininjurywithneuronaldysfunctionthathasseveralpathophysiologiccauses.Strokescanbedividedinto2types:hemorrhagicorischemic.Acuteischemicstrokeiscausedbythromboticorembolicocclusionofacerebralartery.(Seetheimagebelow.)


Nearly800,000peoplesufferstrokeseachyearintheUnitedStates8292%ofthesestrokesareischemic.Strokeisthefourthleadingcauseofadultdeathanddisability,resultinginover$72billioninannualcost.[6]

Ischemicandhemorrhagicstrokecannotbereliablydifferentiatedonthebasisofclinicalexaminationfindingsalone.Furtherevaluation,especiallywithbrainimagingtests(ie,computedtomography[CT]scanningormagneticresonanceimaging[MRI]),isrequired.(SeeWorkup.)

Strokecategories

ThesystemofcategorizingstrokedevelopedinthemulticenterTrialofORG10172inAcuteStrokeTreatment(TOAST)dividesischemicstrokesintothefollowing3majorsubtypes[4]:

LargearterySmallvessel,orlacunarCardioembolicinfarction

Largearteryinfarctionsofteninvolvethromboticinsituocclusionsonatheroscleroticlesionsinthecarotid,vertebrobasilar,andcerebralarteries,typicallyproximaltomajorbrancheshowever,largearteryinfarctionsmayalsobecardioembolic.

Cardiogenicemboliareacommonsourceofrecurrentstroke.Theymayaccountforupto20%ofacutestrokesandhavebeenreportedtohavethehighest1monthmortality.[7](SeePathophysiology.)

Treatment

Recanalizationstrategies,includingintravenousrecombinanttissuetypeplasminogenactivator(rtPA)andintraarterialapproaches,attempttoestablishrevascularizationsothatcellsintheischemicpenumbra(ametabolicallyactiveregion,peripheraltotheischemicarea,wherebloodflowisreduced)canberescuedbeforeirreversibleinjuryoccurs.Restoringbloodflowcanmitigatetheeffectsofischemiaonlyifperformedquickly.

TheUSFoodandDrugAdministration(FDA)hasapprovedtheuseofrtPAinpatientswhomeetcriteriasetforthbytheNationalInstituteofNeurologicDisordersandStroke(NINDS).Inparticular,rtPAmustbegivenwithin3hoursofstrokeonsetandonlyafterCTscanninghasruledouthemorrhagicstroke.

OnthebasisofrecentEuropeandata,theAmericanHeartAssociationandAmericanStrokeAssociationrecommendedexpandingthewindowoftreatmentfrom3hoursto4.5hours,withmorestringentexclusioncriteriaforthelaterperiod(seeTreatment).TheFDAhasnotyetapprovedrtPAforthisexpandedindication,butthishasbecomethecommunitystandardinmanyinstitutions.

Otheraspectsoftreatmentforacuteischemicstrokeincludethefollowing:

Treatmentofneurologiccomplications

Supplementaloxygenasrequired



AntiplatelettherapyGlycemiccontrolOptimalbloodpressurecontrolPreventionofhyperthermia

SeealsoHemorrhagicStroke.

AnatomyThebrainisthemostmetabolicallyactiveorganinthebody.Whilerepresentingonly2%ofthebody'smass,itrequires1520%ofthetotalrestingcardiacoutputtoprovidethenecessaryglucoseandoxygenforitsmetabolism.

Knowledgeofcerebrovasculararterialanatomyandtheterritoriessuppliedbythecerebralarteriesisusefulindeterminingwhichvesselsareinvolvedinacutestroke.Atypicalpatternsofbrainischemiathatdonotconformtospecificvasculardistributionsmayindicateadiagnosisotherthanischemicstroke,suchasvenousinfarction.

Arterialdistributions

Inasimplifiedmodel,thecerebralhemispheresaresuppliedby3pairedmajorarteries,specifically,theanterior,middle,andposteriorcerebralarteries.

Theanteriorandmiddlecerebralarteriescarrytheanteriorcirculationandarisefromthesupraclinoidinternalcarotidarteries.Theanteriorcerebralartery(ACA)suppliesthemedialportionofthefrontalandparietallobesandanteriorportionsofbasalgangliaandanteriorinternalcapsule.(Seetheimagebelow.)

Lateralviewofacerebralangiogramillustratesthebranchesoftheanteriorcerebralartery(ACA)andSylviantriangle.ThepericallosalarteryhasbeendescribedtoarisedistaltotheanteriorcommunicatingarteryordistaltotheoriginofthecallosomarginalbranchoftheACA.ThesegmentalanatomyoftheACAhasbeendescribedasfollows:theA1segmentextendsfromtheinternalcarotidartery(ICA)bifurcationtotheanteriorcommunicatingarteryA2extendstothejunctionoftherostrumandgenuofthecorpuscallosumA3extendsintothebendofthegenuofthecorpuscallosumA4andA5extendposteriorlyabovethecallosalbodyandsuperiorportionofthesplenium.TheSylviantriangleoverliestheopercularbranchesofthemiddlecerebralartery(MCA),withtheapexrepresentingtheSylvianpoint.

Themiddlecerebralartery(MCA)suppliesthelateralportionsofthefrontalandparietallobes,aswellastheanteriorandlateralportionsofthetemporallobes,andgivesrisetoperforatingbranchestotheglobuspallidus,putamen,andinternalcapsule.TheMCAisthedominantsourceofvascularsupplytothehemispheres.(Seetheimagesbelow.)

Thesupratentorialvascularterritoriesofthemajorcerebralarteriesaredemonstratedsuperimposedonaxial(left)andcoronal(right)T2weightedimagesthroughthelevelofthebasalgangliaandthalami.Themiddlecerebralartery(MCAred)suppliesthelateralaspectsofthehemispheres,includingthelateralfrontal,parietal,andanteriortemporallobesinsulaandbasalganglia.Theanteriorcerebralartery(ACAblue)suppliesthemedialfrontalandparietallobes.Theposteriorcerebralartery(PCAgreen)suppliesthethalamiandoccipitalandinferiortemporallobes.Theanteriorchoroidalartery(yellow)suppliestheposteriorlimboftheinternalcapsuleandpartofthehippocampusextendingtotheanteriorandsuperiorsurfaceoftheoccipitalhornofthelateralventricle.

Frontalviewofacerebralangiogramwithselectiveinjectionoftheleftinternalcarotidartery(ICA)illustratestheanteriorcirculation.Theanteriorcerebralartery(ACA)consistsoftheA1segmentproximaltotheanteriorcommunicatingartery,withtheA2segmentdistaltoit.Themiddlecerebralartery(MCA)canbedividedinto4segments:theM1(horizontalsegment)extendstotheanteriorbasalportionoftheinsularcortex(thelimeninsulae)andgivesofflaterallenticulostriatebranches,theM2(insularsegment),M3(opercularbranches),andM4(distalcorticalbranchesonthelateralhemisphericconvexities).

Theposteriorcerebralarteriesarisefromthebasilararteryandcarrytheposteriorcirculation.Theposteriorcerebralartery(PCA)givesrisetoperforatingbranchesthatsupplythethalamiandbrainstemandthecorticalbranchestotheposteriorandmedialtemporallobesandoccipitallobes.(SeeTable1,below.)

Thecerebellarhemispheresaresuppliedasfollows:

Inferiorlybytheposteriorinferiorcerebellarartery(PICA),arisingfromthevertebralartery(seetheimagebelow)



Frontalprojectionfromarightvertebralarteryangiogramillustratestheposteriorcirculation.Thevertebralarteriesjointoformthebasilarartery.Theposteriorinferiorcerebellararteries(PICAs)arisefromthedistalvertebralarteries.Theanteriorinferiorcerebellararteries(AICAs)arisefromtheproximalbasilarartery.Thesuperiorcerebellararteries(SICAs)arisedistallyfromthebasilararterypriortoitsbifurcationintotheposteriorcerebralarteries(PCAs).

SuperiorlybythesuperiorcerebellararteryAnterolaterallybytheanteriorinferiorcerebellarartery(AICA),fromthebasilarartery

Table1.VascularSupplytotheBrain(OpenTableinanewwindow)

VASCULARTERRITORY StructuresSuppliedAnteriorCirculation(Carotid)AnteriorCerebralArtery Corticalbranches:medialfrontalandparietallobe

Mediallenticulostriatebranches:caudatehead,globuspallidus,anteriorlimbofinternalcapsule

MiddleCerebralArtery Corticalbranches:lateralfrontalandparietallobeslateralandanteriortemporallobe

Laterallenticulostriatebranches:globuspallidusandputamen,internalcapsule

AnteriorChoroidalArtery Optictracts,medialtemporallobe,ventrolateralthalamus,coronaradiata,posteriorlimboftheinternalcapsule

PosteriorCirculation(Vertebrobasilar)PosteriorCerebralArtery Corticalbranches:occipitallobes,medialandposteriortemporalandparietallobes

Perforatingbranches:brainstem,posteriorthalamusandmidbrain

PosteriorInferiorCerebellarArtery

Inferiorvermisposteriorandinferiorcerebellarhemispheres

AnteriorInferiorCerebellarArtery

Anterolateralcerebellum

SuperiorCerebellarArtery Superiorvermissuperiorcerebellum

PathophysiologyAcuteischemicstrokesresultfromvascularocclusionsecondarytothromboembolicdisease(seeEtiology).Ischemiacausescellhypoxiaanddepletionofcellularadenosinetriphosphate(ATP).WithoutATP,thereisnolongertheenergytomaintainionicgradientsacrossthecellmembraneandcelldepolarization.Influxofsodiumandcalciumionsandpassiveinflowofwaterintothecellleadtocytotoxicedema.[8,9,10]

Ischemiccoreandpenumbra

Anacutevascularocclusionproducesheterogeneousregionsofischemiaintheaffectedvascularterritory.Localbloodflowislimitedtoanyresidualflowinthemajorarterialsourceplusthecollateralsupply,ifany.

Affectedregionswithcerebralbloodflowoflowerthan10mL/100goftissue/minarereferredtocollectivelyasthecore.Thesecellsarepresumedtodiewithinminutesofstrokeonset.[11]

Zonesofdecreasedormarginalperfusion(cerebralbloodflow



systemsfail.Disruptionofcellularmetabolismalsoimpairsnormalsodiumpotassiumplasmamembranepumps,producinganintracellularincreaseinsodium,whichinturnsincreasesintracellularwatercontent.Thiscellularswellingisreferredtoascytotoxicedemaandoccursveryearlyincerebralischemia.

Cerebralischemiaimpairsthenormalsodiumcalciumexchangeproteinalsofoundoncellplasmamembranes.Theresultinginfluxofcalciumleadstothereleaseofanumberofneurotransmitters,includinglargequantitiesofglutamate,whichinturnactivatesNmethylDaspartate(NMDA)andotherexcitatoryreceptorsonotherneurons.

Theseneuronsthenbecomedepolarized,causingfurthercalciuminflux,furtherglutamaterelease,andlocalamplificationoftheinitialischemicinsult.Thismassivecalciuminfluxalsoactivatesvariousdegradativeenzymes,leadingtothedestructionofthecellmembraneandotheressentialneuronalstructures.[12]Freeradicals,arachidonicacid,andnitricoxidearegeneratedbythisprocess,whichleadstofurtherneuronaldamage.

Ischemiaalsodirectlyresultsindysfunctionofthecerebralvasculature,withbreakdownofthebloodbrainbarrieroccurringwithin46hoursafterinfarction.Followingthebarriersbreakdown,proteinsandwaterfloodintotheextracellularspace,leadingtovasogenicedema.Thisproducesgreaterlevelsofbrainswellingandmasseffectthatpeakat35daysandresolveoverthenextseveralweekswithresorptionofwaterandproteins.[13,14]

Withinhourstodaysafterastroke,specificgenesareactivated,leadingtotheformationofcytokinesandotherfactorsthat,inturn,causefurtherinflammationandmicrocirculatorycompromise.[12]Ultimately,theischemicpenumbraisconsumedbytheseprogressiveinsults,coalescingwiththeinfarctedcore,oftenwithinhoursoftheonsetofthestroke.

Infarctionresultsinthedeathofastrocytes,aswellasthesupportingoligodendroglialandmicroglialcells.Theinfarctedtissueeventuallyundergoesliquefactionnecrosisandisremovedbymacrophages,withthedevelopmentofparenchymalvolumeloss.Awellcircumscribedregionofcerebrospinalfluidlikelowdensity,resultingfromencephalomalaciaandcysticchange,iseventuallyseen.Theevolutionofthesechronicchangesmaybeseenintheweekstomonthsfollowingtheinfarction.(Seetheimagesbelow.)

Vasculardistributions:Middlecerebralartery(MCA)infarction.Noncontrastcomputedtomography(CT)scanningdemonstratesalargeacuteinfarctionintheMCAterritoryinvolvingthelateralsurfacesoftheleftfrontal,parietal,andtemporallobes,aswellastheleftinsularandsubinsularregions,withmasseffectandrightwardmidlineshift.Thereissparingofthecaudateheadandatleastpartofthelentiformnucleusandinternalcapsule,whichreceivebloodsupplyfromthelaterallenticulostriatebranchesoftheM1segmentoftheMCA.Notethelackofinvolvementofthemedialfrontallobe(anteriorcerebralartery[ACA]territory),thalami,andparamedianoccipitallobe(posteriorcerebralartery[PCA]territory).

Vasculardistributions:Anteriorcerebralartery(ACA)infarction.Diffusionweightedimageontheleftdemonstrateshighsignalintheparamedianfrontalandhighparietalregions.TheoppositediffusionweightedimageinadifferentpatientdemonstratesrestricteddiffusioninalargerACAinfarctioninvolvingtheleftparamedianfrontalandposteriorparietalregions.Thereisalsoinfarctionofthelateraltemporoparietalregionsbilaterally(bothmiddlecerebralartery[MCA]distributions),greaterontheleftindicatingmultivesselinvolvementandsuggestingemboli.

Vasculardistributions:Posteriorcerebralartery(PCA)infarction.Thenoncontrastcomputedtomography(CT)imagesdemonstratePCAdistributioninfarctioninvolvingtherightoccipitalandinferomedialtemporallobes.Theimageontherightdemonstratesadditionalinvolvementofthethalamus,alsopartofthePCAterritory.

Vasculardistributions:Anteriorchoroidalarteryinfarction.Thediffusionweightedimage(left)demonstrateshighsignalwithassociatedsignaldropoutontheapparentdiffusioncoefficient(ADC)mapinvolvingtheposteriorlimboftheinternalcapsule.Thisisthetypicaldistributionoftheanteriorchoroidalartery,thelastbranchoftheinternalcarotidartery(ICA)beforebifurcatingintotheanteriorandmiddlecerebralarteries.Theanteriorchoroidalarterymayalsoarisefromthemiddlecerebralartery(MCA).

Hemorrhagictransformationofischemicstroke

Hemorrhagictransformationrepresentstheconversionofanischemicinfarctionintoanareaofhemorrhage.Thisisestimatedtooccurin5%ofuncomplicatedischemicstrokes,intheabsenceoffibrinolytictreatment.Hemorrhagictransformationisnotalwaysassociatedwithneurologicdecline,withtheconversionrangingfromthedevelopmentofsmallpetechialhemorrhagestotheformationofhematomasthatproduceneurologicdeclineandmay



necessitatesurgicalevacuationordecompressivehemicraniectomy.

Proposedmechanismsforhemorrhagictransformationincludereperfusionofischemicallyinjuredtissue,eitherfromrecanalizationofanoccludedvesselorfromcollateralbloodsupplytotheischemicterritoryordisruptionofthebloodbrainbarrier.Withdisruptionofthebloodbrainbarrier,redbloodcellsextravasatefromtheweakenedcapillarybed,producingpetechialhemorrhageormorefrankintraparenchymalhematoma.[8,15,16]

Hemorrhagictransformationofanischemicinfarctoccurswithin214dayspostictus,usuallywithinthefirstweek.Itismorecommonlyseenfollowingcardioembolicstrokesandismorelikelytooccurwithlargerinfarctvolumes.[5,8,17]HemorrhagictransformationisalsomorelikelyfollowingadministrationofrtPAinpatientswhosenoncontrastCT(NCCT)scansdemonstrateareasofhypodensity.[18,19,20]

Poststrokecerebraledemaandseizures

Althoughclinicallysignificantcerebraledemacanoccurafteranteriorcirculationischemicstroke,itisthoughttobesomewhatrare(1020%).[3]Edemaandherniationarethemostcommoncausesofearlydeathinpatientswithhemisphericstroke.

Seizuresoccurin223%ofpatientswithinthefirstdaysafterischemicstroke.[3]Afractionofpatientswhohaveexperiencedstrokedevelopchronicseizuredisorders.

EtiologyIschemicstrokesresultfromeventsthatlimitorstopbloodflow,suchasextracranialorintracranialthromboticembolism,thrombosisinsitu,orrelativehypoperfusion.Asbloodflowdecreases,neuronsceasefunctioning.Althougharangeofthresholdshasbeendescribed,irreversibleneuronalischemiaandinjuryisgenerallythoughttobeginatbloodflowratesoflessthan18mL/100goftissue/min,withcelldeathoccurringrapidlyatratesbelow10mL/100goftissue/min

Riskfactors

Riskfactorsforischemicstrokeincludemodifiableandnonmodifiableconditions.Identificationofriskfactorsineachpatientcanuncovercluestothecauseofthestrokeandthemostappropriatetreatmentandsecondarypreventionplan.

Nonmodifiableriskfactorsincludethefollowing(althoughtherearelikelymanyothers):

AgeRaceSexEthnicityHistoryofmigraineheadaches[21]FibromusculardysplasiaHeredity:Familyhistoryofstrokeortransientischemicattacks(TIAs)

Inaprospectivestudyof27,860womenaged45yearsorolderwhowereparticipatingintheWomen'sHealthStudy,Kurthetalfoundthatmigrainewithaurawasastrongriskfactorforanytypeofstroke.Theadjustedincidenceofthisriskfactorper1000womenperyearwassimilartothoseofotherknownriskfactors,includingsystolicbloodpressure180mmHgorhigher,bodymassindex35kg/m2orgreater,historyofdiabetes,familyhistoryofmyocardialinfarction,andsmoking.[22]

Formigrainewithaura,thetotalincidenceofstrokeinthestudywas4.3per1000womenperyear,theincidenceofischemicstrokewas3.4per1000peryear,andtheincidenceofhemorrhagicstrokewas0.8per1000peryear.

Modifiableriskfactorsincludethefollowing[23]:

Hypertension(themostimportant)DiabetesmellitusCardiacdisease:Atrialfibrillation,valvulardisease,heartfailure,mitralstenosis,structuralanomaliesallowingrighttoleftshunting(eg,patentforamenovale),andatrialandventricularenlargementHypercholesterolemiaTIAsCarotidstenosisHyperhomocystinemiaLifestyleissues:Excessivealcoholintake,tobaccouse,illicitdruguse,physicalinactivity[24]ObesityOralcontraceptiveuse/postmenopausalhormoneuseSicklecelldisease

In2014,theAmericanHeartAssociationandtheAmericanStrokeAssociationissuedguidelinesforthereductionofstrokeriskspecificallyinwomen.Thesegenderspecificrecommendationsincludethefollowing[25,26]:

AstrokeriskscoreshouldbedevelopedspecificallyforwomenWomenwithahistoryofhighbloodpressurebeforepregnancyshouldbeconsideredforlowdoseaspirinand/orcalciumsupplementtreatmenttoreducetheriskofpreeclampsiaBloodpressuremedicationmaybeconsideredforpregnantwomenwithmoderatelyhighbloodpressure(150159mmHg/100109mmHg),andpregnantwomenwithseverehighbloodpressure(160/110mmHgorabove)shouldbetreatedWomenshouldbescreenedforhighbloodpressurebeforetheystartusingbirthcontrolpillsbecauseofanincreasedriskofstrokeWomenwithmigraineheadacheswithaurashouldbeencouragedtoquitsmokingtoreducetheriskofstrokeWomenoverage75shouldbescreenedforatrialfibrillation

Geneticandinflammatorymechanisms



Evidencecontinuestoaccumulatethatinflammationandgeneticfactorshaveimportantrolesinthedevelopmentofatherosclerosisand,specifically,instroke.Accordingtothecurrentparadigm,atherosclerosisisnotablandcholesterolstoragedisease,aspreviouslythought,butadynamic,chronic,inflammatoryconditioncausedbyaresponsetoendothelialinjury.

Traditionalriskfactors,suchasoxidizedlowdensitylipoprotein(LDL)cholesterolandsmoking,contributetothisinjury.Ithasbeensuggested,however,thatinfectionsmayalsocontributetoendothelialinjuryandatherosclerosis.

Hostgeneticfactors,moreover,maymodifytheresponsetotheseenvironmentalchallenges,althoughinheritedriskforstrokeislikelymultigenic.Evenso,specificsinglegenedisorderswithstrokeasacomponentofthephenotypedemonstratethepotencyofgeneticsindeterminingstrokerisk.

Anumberofgenesareknowntoincreasesusceptibilitytoischemicstroke.MutationstotheF2andF5genesarerelativelycommoninthegeneralpopulationandincreasetheriskofthrombosis.Mutationsinthefollowinggenesalsoareknowntoincreasetheriskofstroke:

NOS3:Anitricoxidesynthetasegeneinvolvedinvascularrelaxation[27]ALOX5AP:Involvedinthemetabolismofarachidonicacid[28]PRKCH:Involvedinmajorsignaltransductionsystems[29]

Hyperhomocysteinemiaandhomocystinuria

Hyperhomocysteinemiaisimplicatedinthepathogenesisofischemicstroke.Themostcommonconcernismutationsinthe5,10methylenetetrahydrofolatereductase(MTHFR)gene.Inmanypopulations,themutantallelefrequencyreachespolymorphicproportions,andtheriskfactorforcerebrovasculardiseaseisrelatedtotheserumlevelofhomocysteine.Furthermore,inpersonswhoarecompoundheterozygotesforMTHFRmutation,ifelevatedhomocysteineisfounditcanbeloweredwithoralfolicacidtherapy.

Inaddition,hyperhomocysteinemiacanbeseenincystathionebetasynthetase(CBS)deficiency,whichisgenerallyreferredtoashomocystinuria.Thisdisorderisinheritedinanautosomalrecessivemanner.Symptomsusuallymanifestearlyinlife.Patientshaveamarfanoidhabitus,ectopialentis,andmyopiaandgenerallyhaveintellectualdisability.[30]

Thromboemboliceventsarethemostcommoncauseofdeathforpatientswithhomocystinuriaandmaybeofanytype,includingmyocardialinfarction.Theriskofhavingavasculareventinhomocystinuriais50%byage30.[31]ItwaspreviouslysuggestedthatpersonswhoareheterozygousformutationsintheCBSgenemayhaveanincreasedriskofcerebrovasculardiseaseaswell,butseveralmorerecentstudiesonthissubjectfailedtoreplicatethisfinding.

Amyloidangiopathies

Amyloidangiopathiesarealsoknowntoincreaseriskforstrokeanddementia.MutationsintheCST3genearecausativeandareinheritedinanautosomaldominantmanner.Suffererswillhavediffusedepositionofamyloid,includinginthebrain.Theonsetofsymptomsistypicallyinthethirdorfourthdecadeoflife,withdeathoccurringbeforeage60years.TheseangiopathiesappeartobemostcommonintheIcelandicpopulation.[32]

CADASIL

Cerebralarteriopathy,autosomaldominant,withsubcorticalinfarctsandleukoencephalopathy(CADASIL),iscausedbymutationsintheNOTCH3gene.Itaffectsthesmallarteriesofthebrain.Strokelikeepisodestypicallyoccuratameanageof46years,withanagerangeof1967years.Whitematterchangesinthebrainaretypicallyevidentbyyoungadulthoodandprogressovertime.[33]

Migraineheadachesoccurin3040%ofpeoplewithCADASIL.Approximately60%ofsymptomaticindividualshavecognitivedeficits,whichcanstartasearlyasage35years,andmanydevelopmultiinfarctdementia.[34]

Othermutations

Genomewideassociationstudieshaverevealedadditionallocithatarecommonlyassociatedwithischemicstroke.Earlyonsetischemicstrokehasbeenfoundtobeassociatedwith2singlenucleotidepolymorphismson2q23.3.[35]

LargevesselstrokehasbeenassociatedwithvariationsinHDAC9,PITX2,andZFHX3.[36]HDAC9islocatedon7p21.1,whilePITX2andZFHX3arelocatedon9p21.Itisofnotethatthe9p21locushasalsobeenassociatedwithcardiovasculardisease.

Apolymorphismat2q36.3wasfoundinwhichadenosinesubstitutionconferredalowerriskofischemicstrokeinanadditivefashion.[37]Anadditionalstudysuggestedanassociationbetweenischemicstrokeandalocuson12p13.[38]

Formoreinformation,seeGeneticandInflammatoryMechanismsinStroke.Inaddition,completeinformationonthefollowingmetabolicdiseasesandstrokecanbefoundinthefollowingmainarticles:

MethylmalonicAcidemiaHomocystinuria/HomocysteinemiaFabryDiseaseMELASSyndromeHyperglycemiaandHypoglycemiainStroke

Largearteryocclusion

Largearteryocclusiontypicallyresultsfromembolizationofatheroscleroticdebrisoriginatingfromthecommonorinternalcarotidarteriesorfromacardiacsource.Asmallernumberoflargearteryocclusionsmayarisefromplaqueulcerationandinsituthrombosis.LargevesselischemicstrokesmorecommonlyaffecttheMCAterritory,withtheACAterritoryaffectedtoalesserdegree.(Seetheimagesbelow.)



Noncontrastcomputedtomography(CT)scanina52yearoldmanwithahistoryofworseningrightsidedweaknessandaphasiademonstratesdiffusehypodensityandsulcaleffacementwithmasseffectinvolvingtheleftanteriorandmiddlecerebralarteryterritoriesconsistentwithacuteinfarction.Therearescatteredcurvilinearareasofhyperdensitynotedsuggestiveofdevelopingpetechialhemorrhageinthislargeareaofinfarction.

Magneticresonanceangiogram(MRA)ina52yearoldmandemonstratesocclusionoftheleftprecavernoussupraclinoidinternalcarotidartery(ICA,redcircle),occlusionorhighgradestenosisofthedistalmiddlecerebralartery(MCA)trunkandattenuationofmultipleM2branches.Thediffusionweightedimage(right)demonstrateshighsignalconfirmedtobetruerestricteddiffusionontheapparentdiffusioncoefficient(ADC)mapconsistentwithacuteinfarction.


Lacunarstrokes

Lacunarstrokesrepresent1320%ofallischemicstrokes.TheyresultfromocclusionofthepenetratingbranchesoftheMCA,thelenticulostriatearteries,orthepenetratingbranchesofthecircleofWillis,vertebralartery,orbasilarartery.Thegreatmajorityoflacunarstrokesarerelatedtohypertension.(Seetheimagebelow.)

Axialnoncontrastcomputedtomography(CT)scandemonstratesafocalareaofhypodensityintheleftposteriorlimboftheinternalcapsuleina60yearoldmanwithacuteonsetofrightsidedweakness.Thelesiondemonstrateshighsignalonthefluidattenuatedinversionrecovery(FLAIR)sequence(middleimage)anddiffusionweightedmagneticresonanceimaging(MRI)scan(rightimage),withlowsignalontheapparentdiffusioncoefficient(ADC)mapsindicatinganacutelacunarinfarction.Lacunarinfarctsaretypicallynomorethan1.5cminsizeandcanoccurinthedeepgraymatterstructures,coronaradiata,brainstem,andcerebellum.

Causesoflacunarinfarctsincludethefollowing:

MicroatheromaLipohyalinosisFibrinoidnecrosissecondarytohypertensionorvasculitisHyalinearteriosclerosisAmyloidangiopathyMicroemboli

Embolicstrokes

Cardiogenicembolimayaccountforupto20%ofacutestrokes.Embolimayarisefromtheheart,theextracranialarteries,includingtheaorticarchor,rarely,therightsidedcirculation(paradoxicalemboli)withsubsequentpassagethroughapatentforamenovale.[39]Sourcesofcardiogenicemboliincludethefollowing:

Valvularthrombi(eg,inmitralstenosisorendocarditisorfromuseofaprostheticvalve)Muralthrombi(eg,inmyocardialinfarction,atrialfibrillation,dilatedcardiomyopathy,orseverecongestiveheartfailure)Atrialmyxoma

Acutemyocardialinfarctionisassociatedwitha23%incidenceofembolicstrokes,ofwhich85%occurinthefirstmonthaftertheinfarction.[40]Embolicstrokestendtohaveasuddenonset,andneuroimagingmaydemonstratepreviousinfarctsinseveralvascularterritoriesormayshowcalcificemboli.



Cardioembolicstrokesmaybeisolated,multipleandinasinglehemisphere,orscatteredandbilateralthelatter2typesindicatemultiplevasculardistributionsandaremorespecificforcardioembolism.Multipleandbilateralinfarctscanbetheresultofembolicshowersorrecurrentemboli.Otherpossibilitiesforsingleandbilateralhemisphericinfarctionsincludeembolioriginatingfromtheaorticarchanddiffusethromboticorinflammatoryprocessesthatcanleadtomultiplesmallvesselocclusions.(Seetheimagebelow.)[41,42]

Cardioembolicstroke:Axialdiffusionweightedimagesdemonstratescatteredfociofhighsignalinthesubcorticalanddeepwhitematterbilaterallyinapatientwithaknowncardiacsourceforembolization.Anareaoflowsignalintheleftgangliocapsularregionmaybesecondarytopriorhemorrhageorsubacutetochroniclacunarinfarct.Recurrentstrokesaremostcommonlysecondarytocardioembolicphenomenon.

Formoreinformation,seeCardioembolicStroke.

Thromboticstrokes

Thrombogenicfactorsmayincludeinjurytoandlossofendothelialcellsthislossexposesthesubendotheliumandresultsinplateletactivationbythesubendothelium,activationoftheclottingcascade,inhibitionoffibrinolysis,andbloodstasis.Thromboticstrokesaregenerallythoughttooriginateonrupturedatheroscleroticplaques.Arterialstenosiscancauseturbulentbloodflow,whichcanpromotethrombusformationatherosclerosis(ie,ulceratedplaques)andplateletadherence.Allcausetheformationofbloodclotsthateitherembolizeoroccludetheartery.

Intracranialatherosclerosismaybethecauseofthromboticstrokeinpatientswithwidespreadatherosclerosis.Inotherpatients,especiallyyoungerpatients,othercausesshouldbeconsidered,includingthefollowing[8,43]:

Hypercoagulablestates(eg,antiphospholipidantibodies,proteinCdeficiency,proteinSdeficiency,pregnancy)SicklecelldiseaseFibromusculardysplasiaArterialdissectionsVasoconstrictionassociatedwithsubstanceabuse(eg,cocaine,amphetamines)

Watershedinfarcts

Vascularwatershed,orborderzone,infarctionsoccuratthemostdistalareasbetweenarterialterritories.Theyarebelievedtobesecondarytoembolicphenomenonortoseverehypoperfusion,asoccurs,forexample,incarotidocclusionorprolongedhypotension.(Seetheimagebelow.)[44,45,46]

Magneticresonanceimaging(MRI)scanwasobtainedina62yearoldmanwithhypertensionanddiabetesandahistoryoftransientepisodesofrightsidedweaknessandaphasia.Thefluidattenuatedinversionrecovery(FLAIR)image(left)demonstratespatchyareasofhighsignalarrangedinalinearfashioninthedeepwhitematter,bilaterally.Thisconfigurationistypicalfordeepborderzone,orwatershed,infarction,inthiscasetheanteriorandposteriormiddlecerebralartery(MCA)watershedareas.Theleftsidedinfarctshavecorrespondinglowsignalontheapparentdiffusioncoefficient(ADC)map(right),signifyingacuity.Anoldleftposteriorparietalinfarctisnotedaswell.

Flowdisturbances

Strokesymptomscanresultfrominadequatecerebralbloodflowbecauseofdecreasedbloodpressure(andspecifically,decreasedcerebralperfusionpressure)orasaresultofhematologichyperviscosityfromsicklecelldiseaseorotherhematologicillnesses,suchasmultiplemyelomaandpolycythemiavera.Intheseinstances,cerebralinjurymayoccurinthepresenceofdamagetootherorgansystems.Formoreinformation,seeBloodDyscrasiasandStroke.

Epidemiology

StrokeistheleadingcauseofdisabilityandthefourthleadingcauseofdeathintheUnitedStates.[47,48]Eachyear,approximately795,000peopleintheUnitedStatesexperiencenew(610,000people)orrecurrent(185,000people)stroke.[6]Epidemiologicstudiesindicatethat8292%ofstrokesintheUnitedStatesareischemic.

AccordingtotheWorldHealthOrganization(WHO),15millionpeoplesufferstrokeworldwideeachyear.Ofthese,5milliondie,andanother5millionareleftpermanentlydisabled.[49]

Race,sex,andagerelateddemographics

IntheUnitedStates,blackshaveanageadjustedriskofdeathfromstrokethatis1.49timesthatofwhites.[50]Hispanicshavealoweroverallincidenceofstrokethanwhitesandblacksbutmorefrequentlacunarstrokesandstrokeatanearlierage.

Menareathigherriskforstrokethanwomenwhitemenhaveastrokeincidenceof62.8per100,000,withdeathbeingthefinaloutcomein26.3%ofcases,whilewomenhaveastrokeincidenceof59per100,000andadeathrateof39.2%.

Althoughstrokeoftenisconsideredadiseaseofelderlypersons,onethirdofstrokesoccurinpersonsyoungerthan



65years.[48]Riskofstrokeincreaseswithage,especiallyinpatientsolderthan64years,inwhom75%ofallstrokesoccur.

PrognosisIntheFraminghamandRochesterstrokestudies,theoverallmortalityrateat30daysafterstrokewas28%,themortalityrateat30daysafterischemicstrokewas19%,andthe1yearsurvivalrateforpatientswithischemicstrokewas77%.However,theprognosisafteracuteischemicstrokevariesgreatlyinindividualpatients,dependingonthestrokeseverityandonthepatientspremorbidcondition,age,andpoststrokecomplications.[4]

AstudyutilizingthelargenationalGetWithTheGuidelinesStrokeregistryfoundthatthebaselineNationalInstitutesofHealthStrokeScale(NIHSS)scorewasthestrongestpredictorofearlymortalityrisk,evenmoresothancurrentlyusedmortalitypredictionmodelsincorporatingmultipleclinicaldata.[51]Cardiogenicemboliareassociatedwiththehighest1monthmortalityinpatientswithacutestroke.

Thepresenceofcomputedtomography(CT)scanevidenceofinfarctionearlyinpresentationhasbeenassociatedwithpooroutcomeandwithanincreasedpropensityforhemorrhagictransformationafterfibrinolytictherapy(seePathophysiology).[5,52,53]Hemorrhagictransformationisestimatedtooccurin5%ofuncomplicatedischemicstrokesintheabsenceoffibrinolytictherapy,althoughitisnotalwaysassociatedwithneurologicdecline.Indeed,hemorrhagictransformationrangesfromthedevelopmentofsmallpetechialhemorrhagestotheformationofhematomasrequiringevacuation.

Acuteischemicstrokehasbeenassociatedwithacutecardiacdysfunctionandarrhythmia,whichthencorrelatewithworsefunctionaloutcomeandmorbidityat3months.Datasuggestthatseverehyperglycemiaisindependentlyassociatedwithpooroutcomeandreducedreperfusioninfibrinolysis,aswellasextensionoftheinfarctedterritory.[54,55,56]

InstrokesurvivorsfromtheFraminghamHeartStudy,31%neededhelpcaringforthemselves,20%neededhelpwhenwalking,and71%hadimpairedvocationalcapacityinlongtermfollowup.Formoreinformation,seetheMedscapeReferencearticleMotorRecoveryinStroke.

PatientEducationPubliceducationmustinvolveallagegroups.Incorporatingstrokeintobasiclifesupport(BLS)andcardiopulmonaryresuscitation(CPR)curriculaisjustonewaytoreachayoungeraudience.Avenuestoreachanaudiencewithahigherstrokeriskcouldincludelocalchurches,employers,andseniororganizationstopromotestrokeawareness.

TheAmericanStrokeAssociation(ASA)advisesthepublictobeawareofthesymptomsofstrokethatareeasilyrecognized,includingthesuddenonsetofanyofthefollowing,andtocall911immediately:

Numbnessorweaknessofface,arm,orleg,especiallyon1sideofthebody

ConfusionDifficultyinspeakingorunderstandingDeteriorationofvisionin1orbotheyesDifficultyinwalking,dizziness,andlossofbalanceorcoordinationSevereheadachewithnoknowncause

Inthespringof2013,theASAlaunchedastrokepubliceducationcampaignthatusestheacronymFASTtoteachthewarningsignsofstrokeandtheimportanceofcalling911,asfollows:

F:FacedroopingA:ArmweaknessS:SpeechdifficultyT:Timetocall911

Forpatienteducationinformation,seetheStrokeHealthCenterandtheBrainandNervousSystemHealthCenter,aswellasStroke,TransientIschemicAttack(TIA,Ministroke),andStrokeRelatedDementia.

ContributorInformationandDisclosuresAuthorEdwardCJauch,MD,MS,FAHA,FACEPProfessor,Director,DivisionofEmergencyMedicine,Professor,DepartmentofNeurosciences,AssociateViceChairofResearch,DepartmentofMedicine,MedicalUniversityofSouthCarolinaCollegeofMedicine

EdwardCJauch,MD,MS,FAHA,FACEPisamemberofthefollowingmedicalsocieties:AmericanCollegeofEmergencyPhysicians,AmericanHeartAssociation,AmericanMedicalAssociation,NationalStrokeAssociation,SocietyforAcademicEmergencyMedicine,andSouthCarolinaMedicalAssociation

Disclosure:GenentechGrant/researchfundsSitePI

Coauthor(s)BrianStettler,MDAssistantProfessor,ProgramDirector,EmergencyMedicineResidencyProgram,DepartmentofEmergencyMedicine,andFacultyGreaterCincinnati/NorthernKentuckyStrokeTeam,UniversityofCincinnati

Disclosure:Nothingtodisclose.

ChiefEditorHelmiLLutsep,MDProfessorandViceChair,DepartmentofNeurology,OregonHealthandScienceUniversitySchoolofMedicineAssociateDirector,OregonStrokeCenter

HelmiLLutsep,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofNeurologyandAmericanStrokeAssociation

Disclosure:StrykerNeurovascularConsultingfeeReviewpanelmembership



AdditionalContributorsJeffreyLArnold,MD,FACEPChairman,DepartmentofEmergencyMedicine,SantaClaraValleyMedicalCenter

JeffreyLArnold,MD,FACEPisamemberofthefollowingmedicalsocieties:AmericanAcademyofEmergencyMedicineandAmericanCollegeofPhysicians


JosephUBecker,MDFellow,GlobalHealthandInternationalEmergencyMedicine,StanfordUniversitySchoolofMedicine

JosephUBecker,MDisamemberofthefollowingmedicalsocieties:AmericanCollegeofEmergencyPhysicians,EmergencyMedicineResidentsAssociation,PhiBetaKappa,andSocietyforAcademicEmergencyMedicine


SalvadorCruzFlores,MD,MPH,FAHA,FCCMProfessorofNeurologyandEpidemiology,SidneyWSouersEndowedChair,DirectorofSouersStrokeInstitute,CerebrovascularandNeurointensiveCareSection,Director,VascularNeurologyFellowshipTrainingProgram,InterimChairman,DepartmentofNeurologyandPsychiatry,StLouisUniversitySchoolofMedicineDirector,NeuroscienceIntensiveCareUnit(5ICU),StLouisUniversityHospital

SalvadorCruzFlores,MD,MPH,FAHA,FCCMisamemberofthefollowingmedicalsocieties:AmericanAcademyofHospiceandPalliativeMedicine,AmericanAcademyofNeurology,AmericanCollegeofPhysicians,AmericanHeartAssociation,AmericanSocietyofNeuroimaging,AmericanStrokeAssociation,NationalStrokeAssociation,NeurocriticalCareSociety,andSocietyofCriticalCareMedicine

Disclosure:AxioincHonorariaReviewpanelmembershipRocheHonorariaReviewpanelmembershipLillyHonorariaReviewpanelmembershipBiotronikHonorariaReviewpanelmembership

JStephenHuff,MDAssociateProfessorofEmergencyMedicineandNeurology,DepartmentofEmergencyMedicine,UniversityofVirginiaSchoolofMedicine

JStephenHuff,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofEmergencyMedicine,AmericanAcademyofNeurology,AmericanCollegeofEmergencyPhysicians,andSocietyforAcademicEmergencyMedicine


RichardSKrause,MDSeniorClinicalFaculty/ClinicalAssistantProfessor,DepartmentofEmergencyMedicine,UniversityofBuffaloStateUniversityofNewYorkSchoolofMedicineandBiomedicalSciences

RichardSKrause,MDisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,AmericanAcademyofEmergencyMedicine,AmericanCollegeofEmergencyPhysicians,andSocietyforAcademicEmergencyMedicine


FranciscoTalavera,PharmD,PhDAdjunctAssistantProfessor,UniversityofNebraskaMedicalCenterCollegeofPharmacyEditorinChief,MedscapeDrugReference

Disclosure:MedscapeSalaryEmployment

CharlesRWiraIII,MDAssistantProfessor,SectionofEmergencyMedicine,YaleUniversitySchoolofMedicineDEMLiaisonandAttendingPhysician,YaleAcuteStrokeService,DepartmentofNeurology,YaleNewHavenHospital

CharlesRWiraIII,MDisamemberofthefollowingmedicalsocieties:AmericanCollegeofEmergencyPhysicians,AmericanHeartAssociation,AmericanStrokeAssociation,NeurocriticalCareSociety,SocietyforAcademicEmergencyMedicine,andSocietyofCriticalCareMedicine


References

1. HughesS.EndovascularStrokeTherapyProvenatLast:MRCLEANPublished.MedscapeMedicalNews[serialonline].Dec172014AccessedDec222014.Availableathttp://www.medscape.com/viewarticle/836744.

2. BerkhemerOA,FransenPS,BeumerD,etal.ARandomizedTrialofIntraarterialTreatmentforAcuteIschemicStroke.NEnglJMed.Dec172014[Medline].

3. [Guideline]AdamsHPJr,delZoppoG,AlbertsMJ,BhattDL,BrassL,FurlanA,etal.Guidelinesfortheearlymanagementofadultswithischemicstroke:aguidelinefromtheAmericanHeartAssociation/AmericanStrokeAssociationStrokeCouncil,ClinicalCardiologyCouncil,CardiovascularRadiologyandInterventionCouncil,andtheAtheroscleroticPeripheralVascularDiseaseandQualityofCareOutcomesinResearchInterdisciplinaryWorkingGroups:theAmericanAcademyofNeurologyaffirmsthevalueofthisguidelineasaneducationaltoolforneurologists.Stroke.May200738(5):1655711.[Medline].

4. AdamsHPJr,DavisPH,LeiraEC,ChangKC,BendixenBH,ClarkeWR,etal.BaselineNIHStrokeScalescorestronglypredictsoutcomeafterstroke:AreportoftheTrialofOrg10172inAcuteStrokeTreatment(TOAST).Neurology.Jul13199953(1):12631.[Medline].

5. Tissueplasminogenactivatorforacuteischemicstroke.TheNationalInstituteofNeurologicalDisordersandStrokertPAStrokeStudyGroup.NEnglJMed.Dec141995333(24):15817.[Medline].

6. RogerVL,GoAS,LloydJonesDM,BenjaminEJ,BerryJD,BordenWB,etal.Heartdiseaseandstroke



statistics2012update:areportfromtheAmericanHeartAssociation.Circulation.Jan32012125(1):e2e220.[Medline].

7. SaccoRL,ShiT,ZamanilloMC,KargmanDE.Predictorsofmortalityandrecurrenceafterhospitalizedcerebralinfarctioninanurbancommunity:theNorthernManhattanStrokeStudy.Neurology.Apr199444(4):62634.[Medline].

8. DonnanGA,FisherM,MacleodM,DavisSM.Stroke.Lancet.May102008371(9624):161223.[Medline].

9. DirnaglU,IadecolaC,MoskowitzMA.Pathobiologyofischaemicstroke:anintegratedview.TrendsNeurosci.Sep199922(9):3917.[Medline].

10. YuanJ,YanknerBA.Apoptosisinthenervoussystem.Nature.Oct122000407(6805):8029.[Medline].

11. LatchawRE,YonasH,HunterGJ,YuhWT,UedaT,SorensenAG,etal.Guidelinesandrecommendationsforperfusionimagingincerebralischemia:Ascientificstatementforhealthcareprofessionalsbythewritinggrouponperfusionimaging,fromtheCouncilonCardiovascularRadiologyoftheAmericanHeartAssociation.Stroke.Apr200334(4):1084104.[Medline].

12. KasnerSE,GrottaJC.Emergencyidentificationandtreatmentofacuteischemicstroke.AnnEmergMed.Nov199730(5):64253.[Medline].

13. GotohO,AsanoT,KoideT,TakakuraK.Ischemicbrainedemafollowingocclusionofthemiddlecerebralarteryintherat.I:Thetimecoursesofthebrainwater,sodiumandpotassiumcontentsandbloodbrainbarrierpermeabilityto125Ialbumin.Stroke.JanFeb198516(1):1019.[Medline].

14. BellBA,SymonL,BranstonNM.CBFandtimethresholdsfortheformationofischemiccerebraledema,andeffectofreperfusioninbaboons.JNeurosurg.Jan198562(1):3141.[Medline].

15. MullinsME,LevMH,SchellingerhoutD,GonzalezRG,SchaeferPW.Intracranialhemorrhagecomplicatingacutestroke:howcommonishemorrhagicstrokeoninitialheadCTscanandhowoftenisinitialclinicaldiagnosisofacutestrokeeventuallyconfirmed?.AJNRAmJNeuroradiol.Oct200526(9):220712.[Medline].

16. LydenPD,ZivinJA.Hemorrhagictransformationaftercerebralischemia:mechanismsandincidence.CerebrovascBrainMetabRev.Spring19935(1):116.[Medline].

17. NighoghossianN,HermierM,AdeleineP,BlancLasserreK,DerexL,HonnoratJ,etal.Oldmicrobleedsareapotentialriskfactorforcerebralbleedingafterischemicstroke:agradientechoT2*weightedbrainMRIstudy.Stroke.Mar200233(3):73542.[Medline].

18. GonzlezRG.Imagingguidedacuteischemicstroketherapy:From"timeisbrain"to"physiologyisbrain".AJNRAmJNeuroradiol.Apr200627(4):72835.[Medline].

19. AlbersGW,AmarencoP,EastonJD,SaccoRL,TealP.Antithromboticandthrombolytictherapyforischemicstroke:theSeventhACCPConferenceonAntithromboticandThrombolyticTherapy.Chest.Sep2004126(3Suppl):483S512S.[Medline].

20. DubeyN,BakshiR,WasayM,DmochowskiJ.Earlycomputedtomographyhypodensitypredictshemorrhageafterintravenoustissueplasminogenactivatorinacuteischemicstroke.JNeuroimaging.Apr200111(2):1848.[Medline].

21. BrooksM.MigraineLinkedtoDoubleRiskforSilentStroke.MedscapeMedicalNews.Availableathttp://www.medscape.com/viewarticle/825451.AccessedMay27,2014.

22. AndersonP.Migrainewithaura'major'contributortoallstroketypes.MedscapeMedicalNews[serialonline].June27,2013AccessedJuly9,2013.Availableathttp://www.medscape.com/viewarticle/806983.

23. [Guideline]GoldsteinLB,BushnellCD,AdamsRJ,AppelLJ,BraunLT,ChaturvediS,etal.Guidelinesfortheprimarypreventionofstroke:aguidelineforhealthcareprofessionalsfromtheAmericanHeartAssociation/AmericanStrokeAssociation.Stroke.Feb201142(2):51784.[Medline].[FullText].

24. KurlS,LaukkanenJA,RauramaaR,LakkaTA,SiveniusJ,SalonenJT.Cardiorespiratoryfitnessandtheriskforstrokeinmen.ArchInternMed.Jul282003163(14):16828.[Medline].

25. BushnellC,McCulloughLD,AwadIA,ChireauMV,FedderWN,FurieKL,etal.GuidelinesforthePreventionofStrokeinWomen:AStatementforHealthcareProfessionalsFromtheAmericanHeartAssociation/AmericanStrokeAssociation.Stroke.Feb62014[Medline].

26. HughesS.FirstAHA/ASAGuidelinestoReduceStrokeRiskinWomen.Medscape[serialonline].Availableathttp://www.medscape.com/viewarticle/820277.AccessedFebruary11,2014.

27. MarsdenPA,HengHH,SchererSW,StewartRJ,HallAV,ShiXM,etal.Structureandchromosomallocalizationofthehumanconstitutiveendothelialnitricoxidesynthasegene.JBiolChem.Aug151993268(23):1747888.[Medline].

28. MillerDK,GillardJW,VickersPJ,SadowskiS,LveillC,ManciniJA,etal.Identificationandisolationofamembraneproteinnecessaryforleukotrieneproduction.Nature.Jan181990343(6255):27881.[Medline].

29. KuboM,HataJ,NinomiyaT,MatsudaK,YonemotoK,NakanoT,etal.AnonsynonymousSNPinPRKCH(proteinkinaseCeta)increasestheriskofcerebralinfarction.NatGenet.Feb200739(2):2127.[Medline].

30. MuddSH,SkovbyF,LevyHL,PettigrewKD,WilckenB,PyeritzRE,etal.Thenaturalhistoryofhomocystinuriaduetocystathioninebetasynthasedeficiency.AmJHumGenet.Jan198537(1):131.[Medline].[FullText].

31. TestaiFD,GorelickPB.Inheritedmetabolicdisordersandstrokepart2:homocystinuria,organicacidurias,andureacycledisorders.ArchNeurol.Feb201067(2):14853.[Medline].



32. JenssonO,GudmundssonG,ArnasonA,BlndalH,PetursdottirI,ThorsteinssonL,etal.HereditarycystatinC(gammatrace)amyloidangiopathyoftheCNScausingcerebralhemorrhage.ActaNeurolScand.Aug198776(2):10214.[Medline].

33. ObersteinSA.DiagnosticstrategiesinCADASIL.Neurology.Jun24200360(12):2020authorreply2020.[Medline].

34. DichgansM.CognitioninCADASIL.Stroke.Mar200940(3Suppl):S457.[Medline].

35. ChengYC,O'ConnellJR,ColeJW,StineOC,DuekerN,McArdlePF,etal.Genomewideassociationanalysisofischemicstrokeinyoungadults.G3(Bethesda).Nov20111(6):50514.[Medline].[FullText].

36. TheInternationalStrokeGeneticsConsortium(ISGC)theWellcomeTrustCaseControlConsortium2(WTCCC2),BellenguezC,BevanS,GschwendtnerA,SpencerCC,etal.GenomewideassociationstudyidentifiesavariantinHDAC9associatedwithlargevesselischemicstroke.NatGenet.Feb5201244(3):32833.[Medline].[FullText].

37. ArreguiM,FisherE,KnppelS,BuijsseB,diGiuseppeR,FritscheA,etal.Significantassociationsofthers2943634(2q36.3)geneticpolymorphismwithadiponectin,highdensitylipoproteincholesterolandischemicstroke.Gene.Feb252012494(2):1905.[Medline].

38. IkramMA,SeshadriS,BisJC,FornageM,DeStefanoAL,AulchenkoYS,etal.Genomewideassociationstudiesofstroke.NEnglJMed.Apr232009360(17):171828.[Medline].[FullText].

39. ArboixA,AlioJ.Acutecardioemboliccerebralinfarction:answerstoclinicalquestions.CurrCardiolRev.Feb20128(1):5467.[Medline].[FullText].

40. WittBJ,BallmanKV,BrownRDJr,MeverdenRA,JacobsenSJ,RogerVL.Theincidenceofstrokeaftermyocardialinfarction:ametaanalysis.AmJMed.Apr2006119(4):354.e19.[Medline].

41. WesselsT,WesselsC,EllsiepenA,ReuterI,TrittmacherS,StolzE.Contributionofdiffusionweightedimagingindeterminationofstrokeetiology.AJNRAmJNeuroradiol.Jan200627(1):359.[Medline].

42. RohJK,KangDW,LeeSH,YoonBW,ChangKH.Significanceofacutemultiplebraininfarctionondiffusionweightedimaging.Stroke.Mar200031(3):68894.[Medline].

43. AdamsH,AdamsR,DelZoppoG,GoldsteinLB.Guidelinesfortheearlymanagementofpatientswithischemicstroke:2005guidelinesupdateascientificstatementfromtheStrokeCounciloftheAmericanHeartAssociation/AmericanStrokeAssociation.Stroke.Apr200536(4):91623.[Medline].

44. DerdeynCP,KhoslaA,VideenTO,FritschSM,CarpenterDL,GrubbRLJr.Severehemodynamicimpairmentandborderzoneregioninfarction.Radiology.Jul2001220(1):195201.[Medline].

45. PollanenMS,DeckJH.Directedembolizationisanalternatecauseofcerebralwatershedinfarction.ArchPatholLabMed.Oct1989113(10):113941.[Medline].

46. WaterstonJA,BrownMM,ButlerP,SwashM.Smalldeepcerebralinfarctsassociatedwithocclusiveinternalcarotidarterydisease.Ahemodynamicphenomenon?.ArchNeurol.Sep199047(9):9537.[Medline].

47. U.S.CentersforDiseaseControlandPreventionandtheHeartDiseaseandStrokeStatistics2007Update,publishedbytheAmericanHeartAssociation.Availableathttp://www.strokecenter.org/patients/stats.htm.AccessedSeptember2008.

48. TowfighiA,SaverJL.StrokedeclinesfromthirdtofourthleadingcauseofdeathintheUnitedStates:historicalperspectiveandchallengesahead.Stroke.Aug201142(8):23515.[Medline].

49. MacKayJ,MensahGA.WorldHealthOrganization.GlobalBurdenofStroke.TheAtlasofHeartDiseaseandStroke.Availableathttp://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf.

50. SchneiderAT,KisselaB,WooD,KleindorferD,AlwellK,MillerR,etal.Ischemicstrokesubtypes:apopulationbasedstudyofincidenceratesamongblacksandwhites.Stroke.Jul200435(7):15526.[Medline].

51. FonarowGC,SaverJL,SmithEE,BroderickJP,KleindorferDO,SaccoRL,etal.Relationshipofnationalinstitutesofhealthstrokescaleto30daymortalityinmedicarebeneficiarieswithacuteischemicstroke.JAmHeartAssoc.Feb20121(1):4250.[Medline].[FullText].

52. vonKummerR,AllenKL,HolleR,BozzaoL,BastianelloS,ManelfeC,etal.Acutestroke:usefulnessofearlyCTfindingsbeforethrombolytictherapy.Radiology.Nov1997205(2):32733.[Medline].

53. HackeW,KasteM,FieschiC,ToniD,LesaffreE,vonKummerR,etal.Intravenousthrombolysiswithrecombinanttissueplasminogenactivatorforacutehemisphericstroke.TheEuropeanCooperativeAcuteStrokeStudy(ECASS).JAMA.Oct41995274(13):101725.[Medline].

54. BrunoA,LevineSR,FrankelMR,BrottTG,LinY,TilleyBC,etal.AdmissionglucoselevelandclinicaloutcomesintheNINDSrtPAStrokeTrial.Neurology.Sep10200259(5):66974.[Medline].

55. BrunoA,BillerJ,AdamsHPJr,ClarkeWR,WoolsonRF,WilliamsLS,etal.Acutebloodglucoselevelandoutcomefromischemicstroke.TrialofORG10172inAcuteStrokeTreatment(TOAST)Investigators.Neurology.Jan15199952(2):2804.[Medline].

56. BairdTA,ParsonsMW,PhanhT,ButcherKS,DesmondPM,TressBM,etal.Persistentpoststrokehyperglycemiaisindependentlyassociatedwithinfarctexpansionandworseclinicaloutcome.Stroke.Sep200334(9):220814.[Medline].

57. MandelzweigL,GoldbourtU,BoykoV,TanneD.Perceptual,social,andbehavioralfactorsassociatedwithdelaysinseekingmedicalcareinpatientswithsymptomsofacutestroke.Stroke.May200637(5):124853.[Medline].

58. NationalInstitutesofHealthStrokeScale.Availableat



http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf.AccessedOctober2008.

59. HuffJS.Strokemimicsandchameleons.EmergMedClinNorthAm.Aug200220(3):58395.[Medline].

60. LibmanRB,WirkowskiE,AlvirJ,RaoTH.Conditionsthatmimicstrokeintheemergencydepartment.Implicationsforacutestroketrials.ArchNeurol.Nov199552(11):111922.[Medline].

61. RuncheyS,McGeeS.Doesthispatienthaveahemorrhagicstroke?:clinicalfindingsdistinguishinghemorrhagicstrokefromischemicstroke.JAMA.Jun92010303(22):22806.[Medline].

62. EastonJD,SaverJL,AlbersGW,AlbertsMJ,ChaturvediS,FeldmannE,etal.Definitionandevaluationoftransientischemicattack:ascientificstatementforhealthcareprofessionalsfromtheAmericanHeartAssociation/AmericanStrokeAssociationStrokeCouncilCouncilonCardiovascularSurgeryandAnesthesiaCouncilonCardiovascularRadiologyandInterventionCouncilonCardiovascularNursingandtheInterdisciplinaryCouncilonPeripheralVascularDisease.TheAmericanAcademyofNeurologyaffirmsthevalueofthisstatementasaneducationaltoolforneurologists.Stroke.Jun200940(6):227693.[Medline].

63. TintinalliJ,KellenG,StapczynskiJ.AmericanCollegeofEmergencyPhysicians.EmergencyMedicine:AComprehensiveStudyGuide.6th.NewYork:McGrawHill2004:13821390.

64. LeiraEC,ChangKC,DavisPH,ClarkeWR,WoolsonRF,HansenMD,etal.Canwepredictearlyrecurrenceinacutestroke?.CerebrovascDis.200418(2):13944.[Medline].

65. MolyneuxAJ,KerrRS,YuLM,ClarkeM,SneadeM,YarnoldJA,etal.Internationalsubarachnoidaneurysmtrial(ISAT)ofneurosurgicalclippingversusendovascularcoilingin2143patientswithrupturedintracranialaneurysms:arandomisedcomparisonofeffectsonsurvival,dependency,seizures,rebleeding,subgroups,andaneurysmocclusion.Lancet.Sep392005366(9488):80917.[Medline].

66. ByrneJV.Theaneurysm"cliporcoil"debate.ActaNeurochir(Wien).Feb2006148(2):11520.[Medline].

67. SorensenAG,BuonannoFS,GonzalezRG,SchwammLH,LevMH,HuangHellingerFR,etal.Hyperacutestroke:evaluationwithcombinedmultisectiondiffusionweightedandhemodynamicallyweightedechoplanarMRimaging.Radiology.May1996199(2):391401.[Medline].

68. GonzlezRG,SchaeferPW,BuonannoFS,SchwammLH,BudzikRF,RordorfG,etal.DiffusionweightedMRimaging:diagnosticaccuracyinpatientsimagedwithin6hoursofstrokesymptomonset.Radiology.Jan1999210(1):15562.[Medline].

69. MarksMP,OlivotJM,KempS,LansbergMG,BammerR,WechslerLR,etal.PatientswithacutestroketreatedwithintravenoustPA36hoursafterstrokeonset:correlationsbetweenMRangiographyfindingsandperfusionanddiffusionweightedimagingintheDEFUSEstudy.Radiology.Nov2008249(2):61423.[Medline].[FullText].

70. SchellingerPD,BryanRN,CaplanLR,DetreJA,EdelmanRR,JaigobinC,etal.Evidencebasedguideline:TheroleofdiffusionandperfusionMRIforthediagnosisofacuteischemicstroke:reportoftheTherapeuticsandTechnologyAssessmentSubcommitteeoftheAmericanAcademyofNeurology.Neurology.Jul13201075(2):17785.[Medline].

71. SorensenAG,CopenWA,OstergaardL,BuonannoFS,GonzalezRG,RordorfG,etal.Hyperacutestroke:simultaneousmeasurementofrelativecerebralbloodvolume,relativecerebralbloodflow,andmeantissuetransittime.Radiology.Feb1999210(2):51927.[Medline].

72. CamerlingoM,CastoL,CensoriB,FerraroB,GazzanigaGC,MamoliA.TranscranialDopplerinacuteischemicstrokeofthemiddlecerebralarteryterritories.ActaNeurolScand.Aug199388(2):10811.[Medline].

73. SagarG,RileyP,VohrahA.Isadmissionchestradiographyofanyclinicalvalueinacutestrokepatients?.ClinRadiol.Jul199651(7):499502.[Medline].

74. MeerwaldtR,SlartRH,vanDamGM,LuijckxGJ,TioRA,ZeebregtsCJ.PET/SPECTimaging:fromcarotidvulnerabilitytobrainviability.EurJRadiol.Apr201074(1):1049.[Medline].

75. HandschuR,PoppeR,RaussJ,NeundrferB,ErbguthF.Emergencycallsinacutestroke.Stroke.Apr200334(4):10059.[Medline].

76. WilliamsJE,RosamondWD,MorrisDL.Strokesymptomattributionandtimetoemergencydepartmentarrival:thedelayinaccessingstrokehealthcarestudy.AcadEmergMed.Jan20007(1):936.[Medline].

77. ZweiflerRM,MendizabalJE,CunninghamS,ShahAK,RothrockJF.Hospitalpresentationafterstrokeinacommunitysample:theMobileStrokeProject.SouthMedJ.Nov200295(11):12638.[Medline].

78. LacyCR,SuhDC,BuenoM,KostisJB.Delayinpresentationandevaluationforacutestroke:StrokeTimeRegistryforOutcomesKnowledgeandEpidemiology(S.T.R.O.K.E.).Stroke.Jan200132(1):639.[Medline].

79. PuolakkaT,VyrynenT,HpplO,SoinneL,KuismaM,LindsbergPJ.Sequentialanalysisofpretreatmentdelaysinstrokethrombolysis.AcadEmergMed.Sep201017(9):9659.[Medline].

80. FordAL,WilliamsJA,SpencerM,McCammonC,KhouryN,SampsonTR,etal.ReducingdoortoneedletimesusingToyota'sleanmanufacturingprinciplesandvaluestreamanalysis.Stroke.Dec201243(12):33958.[Medline].[FullText].

81. [BestEvidence]BrunoA,KentTA,CoullBM,ShankarRR,SahaC,BeckerKJ,etal.Treatmentofhyperglycemiainischemicstroke(THIS):arandomizedpilottrial.Stroke.Feb200839(2):3849.[Medline].

82. BellolioMF,GilmoreRM,SteadLG.Insulinforglycaemiccontrolinacuteischaemicstroke.CochraneDatabaseSystRev.Sep720119:CD005346.[Medline].

83. HackeW,KasteM,BluhmkiE,BrozmanM,DvalosA,GuidettiD,etal.Thrombolysiswithalteplase3to4.5hoursafteracuteischemicstroke.NEnglJMed.Sep252008359(13):131729.[Medline].



84. [Guideline]DelZoppoGJ,SaverJL,JauchEC,AdamsHPJr.Expansionofthetimewindowfortreatmentofacuteischemicstrokewithintravenoustissueplasminogenactivator:ascienceadvisoryfromtheAmericanHeartAssociation/AmericanStrokeAssociation.Stroke.Aug200940(8):29458.[Medline].[FullText].

85. WahlgrenN,AhmedN,DvalosA,HackeW,MillnM,MuirK,etal.Thrombolysiswithalteplase34.5hafteracuteischaemicstroke(SITSISTR):anobservationalstudy.Lancet.Oct112008372(9646):13039.[Medline].

86. [BestEvidence]JauchEC,SaverJL,AdamsHPJr,BrunoA,ConnorsJJ,DemaerschalkBM,etal.GuidelinesfortheEarlyManagementofPatientsWithAcuteIschemicStroke:AGuidelineforHealthcareProfessionalsFromtheAmericanHeartAssociation/AmericanStrokeAssociation.Stroke.Jan312013[Medline].

87. BrooksM.StrokeaRaceAgainsttheClock,ReviewConfirms.MedscapeMedicalNews.Availableathttp://www.medscape.com/viewarticle/830611.AccessedSeptember2,2014.

88. EmbersonJ,LeesKR,LydenP,BlackwellL,AlbersG,BluhmkiE,etal.Effectoftreatmentdelay,age,andstrokeseverityontheeffectsofintravenousthrombolysiswithalteplaseforacuteischaemicstroke:ametaanalysisofindividualpatientdatafromrandomisedtrials.Lancet.Aug52014[Medline].

89. StrbianD,RinglebP,MichelP,etal.Ultraearlyintravenousstrokethrombolysis:doallpatientsbenefitsimilarly?.Stroke.Aug222013[Medline].

90. BrooksM.'UltraEarly'ThrombolysisCutsDisabilityinMildStroke.MedscapeMedicalNews[serialonline].Aug282013AccessedSep32013.Availableathttp://www.medscape.com/viewarticle/810126.

91. [BestEvidence]DiedlerJ,AhmedN,SykoraM,UyttenboogaartM,OvergaardK,LuijckxGJ,etal.Safetyofintravenousthrombolysisforacuteischemicstrokeinpatientsreceivingantiplatelettherapyatstrokeonset.Stroke.Feb201041(2):28894.[Medline].

92. AlexandrovAV,MolinaCA,GrottaJC,GaramiZ,FordSR,AlvarezSabinJ,etal.Ultrasoundenhancedsystemicthrombolysisforacuteischemicstroke.NEnglJMed.Nov182004351(21):21708.[Medline].

93. TsivgoulisG,EggersJ,RiboM,PerrenF,SaqqurM,RubieraM,etal.Safetyandefficacyofultrasoundenhancedthrombolysis:acomprehensivereviewandmetaanalysisofrandomizedandnonrandomizedstudies.Stroke.Feb201041(2):2807.[Medline].

94. BroderickJP,PaleschYY,DemchukAM,YeattsSD,KhatriP,HillMD,etal.EndovasculartherapyafterintravenoustPAversustPAaloneforstroke.NEnglJMed.Mar72013368(10):893903.[Medline].[FullText].

95. SchonewilleWJ,WijmanCA,MichelP,RueckertCM,WeimarC,MattleHP,etal.TreatmentandoutcomesofacutebasilararteryocclusionintheBasilarArteryInternationalCooperationStudy(BASICS):aprospectiveregistrystudy.LancetNeurol.Aug20098(8):72430.[Medline].

96. LindsbergPJ,MattleHP.Therapyofbasilararteryocclusion:asystematicanalysiscomparingintraarterialandintravenousthrombolysis.Stroke.Mar200637(3):9228.[Medline].

97. CAST:randomisedplacebocontrolledtrialofearlyaspirinusein20,000patientswithacuteischaemicstroke.CAST(ChineseAcuteStrokeTrial)CollaborativeGroup.Lancet.Jun71997349(9066):16419.[Medline].

98. TheInternationalStrokeTrial(IST):arandomisedtrialofaspirin,subcutaneousheparin,both,orneitheramong19435patientswithacuteischaemicstroke.InternationalStrokeTrialCollaborativeGroup.Lancet.May311997349(9065):156981.[Medline].

99. Abciximabinacuteischemicstroke:arandomized,doubleblind,placebocontrolled,doseescalationstudy.TheAbciximabinIschemicStrokeInvestigators.Stroke.Mar200031(3):6019.[Medline].

100. AdamsHPJr,EffronMB,TornerJ,DvalosA,FrayneJ,TealP,etal.Emergencyadministrationofabciximabfortreatmentofpatientswithacuteischemicstroke:resultsofaninternationalphaseIIItrial:AbciximabinEmergencyTreatmentofStrokeTrial(AbESTTII).Stroke.Jan200839(1):8799.[Medline].

101. SareGM,GeeganageC,BathPM.Highbloodpressureinacuteischaemicstrokebroadeningtherapeutichorizons.CerebrovascDis.200927Suppl1:15661.[Medline].

102. PotterJF,RobinsonTG,FordGA,MistriA,JamesM,ChernovaJ,etal.Controllinghypertensionandhypotensionimmediatelypoststroke(CHHIPS):arandomised,placebocontrolled,doubleblindpilottrial.LancetNeurol.Jan20098(1):4856.[Medline].

103. SandsetEC,BathPM,BoysenG,JatuzisD,KrvJ,LdersS,etal.Theangiotensinreceptorblockercandesartanfortreatmentofacutestroke(SCAST):arandomised,placebocontrolled,doubleblindtrial.Lancet.Feb262011377(9767):74150.[Medline].

104. JeffreyS.CATIS:NoBenefitofBPReductioninAcutePhaseofStroke.MedscapeMedicalNews.Availableathttp://www.medscape.com/viewarticle/814531.AccessedNovember24,2013.

105. HeJ,ZhangY,XuT,ZhaoQ,WangD,ChenCS,etal.EffectsofImmediateBloodPressureReductiononDeathandMajorDisabilityinPatientsWithAcuteIschemicStroke:TheCATISRandomizedClinicalTrial.JAMA.Nov172013[Medline].

106. GobinYP,StarkmanS,DuckwilerGR,GrobelnyT,KidwellCS,JahanR,etal.MERCI1:aphase1studyofMechanicalEmbolusRemovalinCerebralIschemia.Stroke.Dec200435(12):284854.[Medline].

107. SmithWS,SungG,StarkmanS,SaverJL,KidwellCS,GobinYP,etal.Safetyandefficacyofmechanicalembolectomyinacuteischemicstroke:resultsoftheMERCItrial.Stroke.Jul200536(7):14328.[Medline].

108. SmithWS,SungG,SaverJ,BudzikR,DuckwilerG,LiebeskindDS,etal.Mechanicalthrombectomyforacuteischemicstroke:finalresultsoftheMultiMERCItrial.Stroke.Apr200839(4):120512.[Medline].



109. BoseA,HenkesH,AlfkeK,ReithW,MayerTE,BerlisA.ThePenumbraSystem:amechanicaldeviceforthetreatmentofacutestrokeduetothromboembolism.AJNRAmJNeuroradiol.Aug200829(7):140913.[Medline].

110. SaverJL,JahanR,LevyEI,JovinTG,BaxterB,NogueiraRG,etal.SolitaireflowrestorationdeviceversustheMerciRetrieverinpatientswithacuteischaemicstroke(SWIFT):arandomised,parallelgroup,noninferioritytrial.Lancet.Oct62012380(9849):12419.[Medline].

111. NogueiraRG,LutsepHL,GuptaR,JovinTG,AlbersGW,WalkerGA,etal.TrevoversusMerciretrieversforthrombectomyrevascularisationoflargevesselocclusionsinacuteischaemicstroke(TREVO2):arandomisedtrial.Lancet.Oct62012380(9849):123140.[Medline].

112. AndersonP.Medicalmanagementstillbestsintracranialstenting.MedscapeMedicalNews[serialonline].October31,2013AccessedNovember5,2013.Availableathttp://www.medscape.com/viewarticle/813604.

113. DerdeynCP,ChimowitzMI,LynnMJ,FiorellaD,TuranTN,JanisLS,etal.Aggressivemedicaltreatmentwithorwithoutstentinginhighriskpatientswithintracranialarterystenosis(SAMMPRIS):thefinalresultsofarandomisedtrial.Lancet.Oct252013[Medline].

114. RothwellPM,MarkusHS.Improvedmedicaltreatmentinsecondarypreventionofstroke.Lancet.Oct252013[Medline].

115. MarionDW.Controllednormothermiainneurologicintensivecare.CritCareMed.Feb200432(2Suppl):S435.[Medline].

116. OlsenTS,WeberUJ,KammersgaardLP.Therapeutichypothermiaforacutestroke.LancetNeurol.Jul20032(7):4106.[Medline].

117. HemmenTM,RamanR,GulumaKZ,MeyerBC,GomesJA,CruzFloresS,etal.Intravenousthrombolysisplushypothermiaforacutetreatmentofischemicstroke(ICTuSL):finalresults.Stroke.Oct201041(10):226570.[Medline].

118. [BestEvidence]denHertogHM,vanderWorpHB,vanGemertHM,AlgraA,KappelleLJ,vanGijnJ,etal.TheParacetamol(Acetaminophen)InStroke(PAIS)trial:amulticentre,randomised,placebocontrolled,phaseIIItrial.LancetNeurol.May20098(5):43440.[Medline].

119. HofmeijerJ,KappelleLJ,AlgraA,AmelinkGJ,vanGijnJ,vanderWorpHB.Surgicaldecompressionforspaceoccupyingcerebralinfarction(theHemicraniectomyAfterMiddleCerebralArteryinfarctionwithLifethreateningEdemaTrial[HAMLET]):amulticentre,open,randomisedtrial.LancetNeurol.Apr20098(4):32633.[Medline].

120. JttlerE,SchwabS,SchmiedekP,UnterbergA,HennericiM,WoitzikJ,etal.DecompressiveSurgeryfortheTreatmentofMalignantInfarctionoftheMiddleCerebralArtery(DESTINY):arandomized,controlledtrial.Stroke.Sep200738(9):251825.[Medline].

121. VahediK,HofmeijerJ,JuettlerE,VicautE,GeorgeB,AlgraA,etal.Earlydecompressivesurgeryinmalignantinfarctionofthemiddlecerebralartery:apooledanalysisofthreerandomisedcontrolledtrials.LancetNeurol.Mar20076(3):21522.[Medline].

122. VahediK,VicautE,MateoJ,KurtzA,OrabiM,GuichardJP,etal.Sequentialdesign,multicenter,randomized,controlledtrialofearlydecompressivecraniectomyinmalignantmiddlecerebralarteryinfarction(DECIMALTrial).Stroke.Sep200738(9):250617.[Medline].

123. WijdicksEF,ShethKN,CarterBS,GreerDM,KasnerSE,KimberlyWT,etal.RecommendationsfortheManagementofCerebralandCerebellarInfarctionWithSwelling:AStatementforHealthcareProfessionalsFromtheAmericanHeartAssociation/AmericanStrokeAssociation.Stroke.Jan302014[Medline].

124. HughesS.AHA/ASAGuidelineonStrokeWithBrainSwelling.Medscape[serialonline].Availableathttp://www.medscape.com/viewarticle/820481.AccessedFebruary25,2014.

125. PadmaV,FisherM,MoonisM.Roleofheparinandlowmolecularweightheparinsinthemanagementofacuteischemicstroke.ExpertRevCardiovascTher.May20064(3):40515.[Medline].

126. CLOTS(ClotsinLegsOrsTockingsafterStroke)TrialsCollaboration.DennisM,SandercockP,ReidJ,GrahamC,ForbesJ,MurrayG.Effectivenessofintermittentpneumaticcompressioninreductionofriskofdeepveinthrombosisinpatientswhohavehadastroke(CLOTS3):amulticentrerandomisedcontrolledtrial.Lancet.Aug102013382(9891):51624.[Medline].

127. CollaborativeoverviewofrandomisedtrialsofantiplatelettherapyI:Preventionofdeath,myocardialinfarction,andstrokebyprolongedantiplatelettherapyinvariouscategoriesofpatients.AntiplateletTrialists'Collaboration.BMJ.Jan81994308(6921):81106.[Medline].[FullText].

128. [BestEvidence]AmarencoP,BogousslavskyJ,CallahanA3rd,GoldsteinLB,HennericiM,RudolphAE,etal.Highdoseatorvastatinafterstrokeortransientischemicattack.NEnglJMed.Aug102006355(6):54959.[Medline].

129. ChimowitzMI,LynnMJ,HowlettSmithH,SternBJ,HertzbergVS,FrankelMR,etal.Comparisonofwarfarinandaspirinforsymptomaticintracranialarterialstenosis.NEnglJMed.Mar312005352(13):130516.[Medline].

130. BaigentC,BlackwellL,CollinsR,EmbersonJ,GodwinJ,PetoR,etal.Aspirinintheprimaryandsecondarypreventionofvasculardisease:collaborativemetaanalysisofindividualparticipantdatafromrandomisedtrials.Lancet.May302009373(9678):184960.[Medline].[FullText].

131. [BestEvidence]RidkerPM,CookNR,LeeIM,GordonD,GazianoJM,MansonJE,etal.Arandomizedtrialoflowdoseaspirinintheprimarypreventionofcardiovasculardiseaseinwomen.NEnglJMed.Mar312005352(13):1293304.[Medline].

132. HughesS.NewAHA/ASAStrokeSecondaryPreventionGuidelines.MedscapeMedicalNews[serialonline].May22014AccessedMay122014.Availableathttp://www.medscape.com/viewarticle/824525.



MedscapeReference2011WebMD,LLC

133. [Guideline]KernanWN,OvbiageleB,BlackHR,etal.GuidelinesforthePreventionofStrokeinPatientsWithStrokeandTransientIschemicAttack:AGuidelineforHealthcareProfessionalsFromtheAmericanHeartAssociation/AmericanStrokeAssociation.Stroke.May12014[Medline].[FullText].

134. GeeganageCM,DienerHC,AlgraA,ChenC,TopolEJ,DenglerR,etal.Dualormonoantiplatelettherapyforpatientswithacuteischemicstrokeortransientischemicattack:systematicreviewandmetaanalysisofrandomizedcontrolledtrials.Stroke.Apr201243(4):105866.[Medline].

135. [BestEvidence]HalkesPH,vanGijnJ,KappelleLJ,KoudstaalPJ,AlgraA.Aspirinplusdipyridamoleversusaspirinaloneaftercerebralischaemiaofarterialorigin(ESPRIT):randomisedcontrolledtrial.Lancet.May202006367(9523):166573.[Medline].

136. [BestEvidence]DenglerR,DienerHC,SchwartzA,GrondM,SchumacherH,MachnigT,etal.Earlytreatmentwithaspirinplusextendedreleasedipyridamolefortransientischaemicattackorischaemicstrokewithin24hofsymptomonset(EARLYtrial):arandomised,openlabel,blindedendpointtrial.LancetNeurol.Feb20109(2):15966.[Medline].

137. DienerHC,BogousslavskyJ,BrassLM,CimminielloC,CsibaL,KasteM,etal.Aspirinandclopidogrelcomparedwithclopidogrelaloneafterrecentischaemicstrokeortransientischaemicattackinhighriskpatients(MATCH):randomised,doubleblind,placebocontrolledtrial.Lancet.Jul24302004364(9431):3317.[Medline].

138. [BestEvidence]ConnollyS,PogueJ,HartR,PfefferM,HohnloserS,ChrolaviciusS,etal.ClopidogrelplusaspirinversusoralanticoagulationforatrialfibrillationintheAtrialfibrillationClopidogrelTrialwithIrbesartanforpreventionofVascularEvents(ACTIVEW):arandomisedcontrolledtrial.Lancet.Jun102006367(9526):190312.[Medline].

139. [Guideline]WannLS,CurtisAB,EllenbogenKA,EstesNA3rd,EzekowitzMD,JackmanWM,etal.2011ACCF/AHA/HRSfocusedupdateonthemanagementofpatientswithatrialfibrillation(updateonDabigatran):areportoftheAmericanCollegeofCardiologyFoundation/AmericanHeartAssociationTaskForceonpracticeguidelines.Circulation.Mar152011123(10):114450.[Medline].[FullText].

140. UchinoK,HernandezAV.Dabigatranassociationwithhigherriskofacutecoronaryevents:metaanalysisofnoninferiorityrandomizedcontrolledtrials.ArchInternMed.Mar122012172(5):397402.[Medline].

141. [Guideline]FurieKL,KasnerSE,AdamsRJ,AlbersGW,BushRL,FaganSC,etal.Guidelinesforthepreventionofstrokeinpatientswithstrokeortransientischemicattack:aguidelineforhealthcareprofessionalsfromtheamericanheartassociation/americanstrokeassociation.Stroke.Jan201142(1):22776.[Medline].[FullText].

142. AndersonP.Waitonelectivesurgeryafterstroke.MedscapeMedicalNews[serialonline].July17,2014AccessedJuly21,2014.Availableathttp://www.medscape.com/viewarticle/828447.

143. ChiongW,KimAS,HuangIA,FarahanyNA,JosephsonSA.Testingthepresumptionofconsenttoemergencytreatmentforacuteischemicstroke.JAMA.Apr23302014311(16):168991.[Medline].

144. EbingerM,WinterB,WendtM,WeberJE,WaldschmidtC,RozanskiM,etal.Effectoftheuseofambulancebasedthrombolysisontimetothrombolysisinacuteischemicstroke:arandomizedclinicaltrial.JAMA.Apr23302014311(16):162231.[Medline].

145. FonarowGC,ZhaoX,SmithEE,SaverJL,ReevesMJ,BhattDL,etal.Doortoneedletimesfortissueplasminogenactivatoradministrationandclinicaloutcomesinacuteischemicstrokebeforeandafteraqualityimprovementinitiative.JAMA.Apr23302014311(16):163240.[Medline].

146. HughesS.DESTINYII:benefitofsurgeryforstrokewithswelling.MedscapeMedicalNews[serialonline].March24,2014AccessedApril1,2014.Availableathttp://www.medscape.com/viewarticle/822472.

147. JeffreyS.TARGET:STROKECutsDoortoNeedleTime,ImprovesOutcomes.MedscapeMedicalNews.Availableathttp://www.medscape.com/viewarticle/824008.AccessedApril29,2014.

148. JrgensenME,TorpPedersenC,GislasonGH,JensenPF,BergerSM,ChristiansenCB,etal.Timeelapsedafterischemicstrokeandriskofadversecardiovasculareventsandmortalityfollowingelectivenoncardiacsurgery.JAMA.Jul162014312(3):26977.[Medline].

149. JttlerE,UnterbergA,WoitzikJ,BselJ,AmiriH,SakowitzOW,etal.Hemicraniectomyinolderpatientswithextensivemiddlecerebralarterystroke.NEnglJMed.Mar202014370(12):1091100.[Medline].

150. RopperAH.Hemicraniectomytohalveorhalvenot.NEnglJMed.Mar202014370(12):115960.[Medline].

151. ShiberJR,FontaneE,AdewaleA.Strokeregistry:hemorrhagicvsischemicstrokes.AmJEmergMed.Mar201028(3):3313.[Medline].

stroke ischemic

Documents

ischemic stroke with increased icp - ksbn.kansas.govi....

ischemic stroke. 2012

ischemic stroke in emergency medicine

ischemic stroke -...

imaging in ischemic stroke

ischemic stroke - providence health &...

management of ischemic stroke

acute ischemic stroke interventions

pathophysiology of acute ischemic stroke

conference_acute ischemic stroke

headache after ischemic stroke - neurology · with ischemic...

acute ischemic stroke drugs

management of acute ischemic stroke and transitory ischemic...

ischemic stroke -...

management of ischemic stroke · efns regional teaching...

ischemic stroke - clinical publishing ebook chp … · for...

quality reporting -...

arterial ischemic stroke (pais)

acute ischemic stroke -...

mapping the ischemic penumbra and predicting stroke...